Vanguard Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $561M | Sell |
|
|||||
|
2025
Q2 | $569M | Buy |
|
|||||
|
2025
Q1 | $615M | Buy |
|
|||||
|
2024
Q4 | $469M | Buy |
|
|||||
|
2024
Q3 | $360M | Buy |
|
|||||
|
2024
Q2 | $244M | Buy |
|
|||||
|
2024
Q1 | $206M | Sell |
|
|||||
|
2023
Q4 | $233M | Buy |
|
|||||
|
2023
Q3 | $113M | Buy |
|
|||||
|
2023
Q2 | $334M | Buy |
|
|||||
|
2023
Q1 | $201M | Sell |
|
|||||
|
2022
Q4 | $183M | Buy |
|
|||||
|
2022
Q3 | $87.3M | Buy |
|
|||||
|
2022
Q2 | $55.3M | Buy |
|
|||||
|
2022
Q1 | $115M | Buy |
|
|||||
|
2021
Q4 | $230M | Buy |
|
|||||
|
2021
Q3 | $400M | Buy |
|
|||||
|
2021
Q2 | $455M | Buy |
|
|||||
|
2021
Q1 | $536M | Buy |
|
|||||
|
2020
Q4 | $571M | Buy |
|
|||||
|
2020
Q3 | $200M | Buy |
|
|||||
|
2020
Q2 | $106M | Buy |
|
|||||
|
2020
Q1 | $43.8M | Buy |
|
|||||
|
2019
Q4 | $47.1M | Buy |
|
|||||
|
2019
Q3 | $22M | Sell |
|
|||||
|
2019
Q2 | $35M | Buy |
|
|||||
|
2019
Q1 | $27.1M | Buy |
|
|||||
|
2018
Q4 | $8.12M | Sell |
|
|||||
|
2018
Q3 | $17.1M | Buy |
|
|||||
|
2018
Q2 | $36.7M | Buy |
|
|||||
|
2018
Q1 | $36.2M | Buy |
|
|||||
|
2017
Q4 | $19.9M | Buy |
|
|||||
|
2017
Q3 | $26.8M | Buy |
|
|||||
|
2017
Q2 | $20.6M | Buy |
|
|||||
|
2017
Q1 | $20.9M | Buy |
|
|||||
|
2016
Q4 | $7.18M | Buy |
|
|||||
|
2016
Q3 | $11.5M | Buy |
|
|||||
|
2016
Q2 | $8.99M | Buy |
|
|||||
|
2016
Q1 | $11.3M | Buy |
|
|||||
|
2015
Q4 | $14.9M | Buy |
|
|||||
|
2015
Q3 | $12.3M | Buy |
|
|||||
|
2015
Q2 | $18.2M | Buy |
|
|||||
|
2015
Q1 | $16.5M | Buy |
|
|||||
|
2014
Q4 | $16.6M | Buy |
|
|||||
|
2014
Q3 | $8.85M | Buy |
|
|||||
|
2014
Q2 | $7.22M | Buy |
|
|||||
|
2014
Q1 | $5.06M | Buy |
|
|||||
|
2013
Q4 | $2.63M | Buy |
|
|||||
|
2013
Q3 | $397K | Buy |
|
|||||
|
2013
Q2 | $177K | Buy |
|